BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16497494)

  • 1. Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts.
    Clavreul A; Sindji L; Aubert-Pouëssel A; Benoît JP; Menei P; Montero-Menei CN
    Eur J Pharm Biopharm; 2006 Jun; 63(2):221-8. PubMed ID: 16497494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.
    Garbayo E; Montero-Menei CN; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
    J Control Release; 2009 Apr; 135(2):119-26. PubMed ID: 19154763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.
    Tatard VM; Sindji L; Branton JG; Aubert-Pouëssel A; Colleau J; Benoit JP; Montero-Menei CN
    Biomaterials; 2007 Apr; 28(11):1978-88. PubMed ID: 17240442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
    McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
    Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
    Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
    Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study of GDNF release from biodegradable PLGA microspheres.
    Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
    J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
    Törnqvist N; Björklund L; Strömberg I
    Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease.
    Jollivet C; Aubert-Pouessel A; Clavreul A; Venier-Julienne MC; Montero-Menei CN; Benoit JP; Menei P
    Neurosci Lett; 2004 Feb; 356(3):207-10. PubMed ID: 15036631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.
    Sajadi A; Bensadoun JC; Schneider BL; Lo Bianco C; Aebischer P
    Neurobiol Dis; 2006 Apr; 22(1):119-29. PubMed ID: 16300956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres.
    Garbayo E; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
    Eur J Pharm Biopharm; 2008 Aug; 69(3):844-51. PubMed ID: 18417331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage.
    Menei P; Pean JM; Nerrière-Daguin V; Jollivet C; Brachet P; Benoit JP
    Exp Neurol; 2000 Jan; 161(1):259-72. PubMed ID: 10683292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
    Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
    Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats.
    Grandoso L; Ponce S; Manuel I; Arrúe A; Ruiz-Ortega JA; Ulibarri I; Orive G; Hernández RM; Rodríguez A; Rodríguez-Puertas R; Zumárraga M; Linazasoro G; Pedraz JL; Ugedo L
    Int J Pharm; 2007 Oct; 343(1-2):69-78. PubMed ID: 17583454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
    Shingo T; Date I; Yoshida H; Ohmoto T
    J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.